breast-cancer
Applying Christensen's disruptive innovation framework to breast cancer therapy: mutation-anchored agents underperform due to resistance escape routes, while broadly acting host-driven therapies (ADCs, immunotherapy, cell/gene therapies) succeed by acting through harder-to-escape mechanisms across…
lung-cancer
NSCLC patients with COPD respond better to anti-PD-1 immunotherapy. COPD-driven epithelial remodeling expands CXCL14+ basal-like tumor cells, which recruit CXCL9+ macrophages via CXCL14-CXCR4 signaling, amplifying cytotoxic T cell infiltration. This tumor-macrophage axis predicts pathological…
cervical-cancer
Survey of 250 Indigenous women in rural Nepal found only 18% knew one prevention behavior for cervical cancer, yet 76.8% were positive toward screening and 81.6% toward HPV vaccination. The barrier is information, not willingness. Culturally tailored health education programs are urgently needed.
colorectal-cancer
Pretreatment ctDNA (circulating tumor DNA) levels measured by affordable mFast-SeqS sequencing classified 19% of 182 colorectal liver metastasis patients as ctDNA-high. These patients had 1-year RFS of 29% vs. 52% and 3-year OS of 48% vs. 78% compared to ctDNA-low patients, and were at higher risk…
lung-cancer
Cancer cachexia is common in NSCLC patients receiving immunotherapy and predicts poor outcomes. Western diagnostic criteria (Fearon) may miss cachexia in Asian patients with lower baseline body mass. In 411 Japanese PD-L1-high NSCLC patients, 40.9% were cachectic by Asian Working Group for Cachexia…
weekly-digest
This week’s research is defined by two powerful tensions: the drive to understand why treatments fail, and the growing case for doing less. On the molecular front, scientists finally cracked open one of oncology’s most frustrating puzzles — why BET inhibitors, which looked extraordinary in the lab, have repeatedly
project-idea
Analysis of 9,000+ patients revealed that only colorectal cancer — not other cancer types — consistently harbors distinct microbial communities, suggesting the gut microbiome has a unique relationship with colorectal carcinogenesis that could be exploited for diagnostics and treatment.
project-idea
Non-cancerous brain support cells were found to promote glioblastoma growth through paracrine signaling, and blocking this communication dramatically slowed tumor growth — revealing that GBM's microenvironment contains targetable vulnerabilities that are being systematically overlooked by drug…
project-idea
BRD2 and BRD4 have fundamentally distinct functions — BRD2 prepares genes for activation while BRD4 triggers transcription — meaning that pan-BET inhibitors have been disrupting gene regulation in counterproductive ways, and the field now needs selective BRD4 inhibitors.
project-idea
Zeaxanthin — a carotenoid supplement already taken for eye health — strengthens T cells and enhances immunotherapy effectiveness in preclinical models, suggesting that common dietary compounds may meaningfully modulate cancer immune responses and warrant systematic investigation.
project-idea
A randomized trial shows active surveillance for DCIS produces similar ipsilateral invasive breast cancer survival as immediate surgery — a landmark result that means thousands of women per year could potentially avoid surgery, but only if they can access clear information to make an informed…
project-idea
Significant incidental findings on lung screening CT are associated with a substantially increased risk of extrapulmonary cancer diagnosis in the following year — meaning lung screening programs are detecting signals for multiple cancer types, but follow-up infrastructure for incidental findings is…
